Discussion List Archives

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[SA_Scat] Postdoctoral researcher at Lund MedicalFaculty/CureVac/Institut Laue-Langevin

  • To: "sa_scat@iucr.org" <sa_scat@iucr.org>
  • Subject: [SA_Scat] Postdoctoral researcher at Lund MedicalFaculty/CureVac/Institut Laue-Langevin
  • From: Trevor Forsyth via sa_scat <sa_scat@iucr.org>
  • Date: Fri, 9 Sep 2022 13:29:35 +0000
  • Accept-Language: en-GB, sv-SE, en-US
Postdoctoral researcher at Lund Medical Faculty/CureVac/Institut Laue-Langevin
We seek a highly motivated  postdoctoral researcher to be based in the Molecular Biophysics Group within the Biomedical Centre (BMC) in the Medical Faculty of Lund University, led by Professor Trevor Forsyth. The project will be carried out in close collaboration with CureVac (https://www.curevac.com/en/ ) in Germany, and with the LSS and Life Sciences Groups at the Institut Laue Langevin (ILL - https://www.ill.eu/ ) in France. CureVac is a leading global clinical-stage biopharmaceutical company dedicated to the development of new classes of drugs based on the use of messenger RNA (mRNA) technologies. The ILL is the most intense neutron source in the world and holds a leading position for neutron science in life sciences, soft condensed matter, and hard condensed matter.The researcher will be based in the Lund Medical Faculty, with good access to state-of-the-art facilities both within the Medical, Science, and Engineering faculties, and in close proximity to the nearby MAX-IV synchrotron and ESS neutron beam facilities, as well as access to the ILL and ESRF sources in Grenoble, France.
The work will focus on the structural characterization of mRNA lipid nanoparticles (LNPs) using techniques such as small-angle X-ray and neutron scattering (SAXS/SANS), selective deuteration, and electron microscopy. We seek advanced structural characterization of mRNA LNPs relating  to pharmaceutical stability  and in vivo efficacy. These structural details are critical for the development of better vaccines in the future.
The desired starting date is December 2022 or by agreement.
To apply for the position, please go to https://lu.varbi.com/en/what:job/jobID:540560/
_______________________________________________sa_scat mailing listsa_scat@iucr.orghttp://mailman.iucr.org/cgi-bin/mailman/listinfo/sa_scat

Reply to: [list | sender only]